Product Information
PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.2814 per EA under NDC 70752017110. Its NADAC has been published 268 times since May 12, 2021.
Strength
50 mg/1
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752017110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PROPYLTHIOURACILApproval Type
Generic (ANDA)
FDA Application
ANDA080154On Market Since
3/18/2021
Pharmacological Classes
Price Statistics
The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 268 times since May 12, 2021, and over the history we have for it it has declined 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2814 per EA |
|---|---|
| All-time high | $0.5497 (Aug 11, 2021) |
| All-time low | $0.2149 (May 22, 2024) |
| 52-week high | $0.3341 |
| 52-week low | $0.2646 |
| Median price | $0.3844 |
| Average price | $0.3808 |
| Largest weekly change | -44.1% (May 22, 2024) |
| Weeks tracked | 268 |
| Tracking since | May 12, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PROPYLTHIOURACIL market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Quagen Pharmaceuticals LLC, is $0.2814 per EA (NDC 70752017110), effective Jun 24, 2026.
How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has declined 42.6%. It has been tracked across 268 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?
Since May 12, 2021, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2149 (May 22, 2024) to a high of $0.5497 (Aug 11, 2021), with a median of $0.3844 per EA.
Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PROPYLTHIOURACIL 50 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PROPYLTHIOURACIL 50 MG TABLET?
PROPYLTHIOURACIL 50 MG TABLET (NDC 70752017110) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification